Sharon J. Bracken, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 3,264 shares at $73.35 ($239K) on 2018-09-28, disclosed to the SEC on 2018-10-02.
Open-market sale of $239k ABT by Senior Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.35 | 100 | $7K | 3.1% |
| 2 | $73.35 | 1,532 | $112K | 46.9% |
| 3 | $73.35 | 1,532 | $112K | 46.9% |
| 4 | $73.36 | 100 | $7K | 3.1% |
| Total | $73.35 avg | 3,264 | $239K | 100% |
| Filing → |
| ABT | SELL | 2018-07-31 | $40K | — | Filing → |
| ABT | SELL | 2018-07-24 | $16K | — | Filing → |
| ABT | SELL | 2018-05-08 | $126K | — | Filing → |